Albert Beraldo
Directeur/Membre du Conseil chez MEDICENNA THERAPEUTICS CORP.
Fortune : 455 000 $ au 30/04/2024
Profil
Albert George Beraldo was the founder of Alveda Pharmaceuticals, Inc. founded in 2006, where he held the titles of President, Chief Executive Officer & Director until 2015.
He currently holds positions as Chairman at Global Transplant Solutions, Inc., Director at Medicenna Therapeutics, Inc., and Lead Independent Non-Executive Director at Medicenna Therapeutics Corp.
since 2016.
Additionally, he is the President of Idoman Ltd.
since 2008.
In his former positions, he was President & Chief Executive Officer at Telesta Therapeutics, Inc. and Bioniche Pharma Group Ltd.
He was also an Independent Non-Executive Director at Telesta Therapeutics, Inc. from 2011 to 2014, a Director at Helix BioPharma Corp.
from 2016 to 2017, and an Independent Director at Pure Global Cannabis, Inc. from 2018 to 2020.
He also worked as a Controller at Vetrepharm Canada, Inc. Mr. Beraldo received his undergraduate degree from the University of Windsor.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/09/2023 | 325 000 ( 0,47% ) | 455 000 $ | 30/04/2024 |
Postes actifs de Albert Beraldo
| Sociétés | Poste | Début |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Directeur/Membre du Conseil | 22/11/2016 |
Medicenna Therapeutics, Inc.
 Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Directeur/Membre du Conseil | - |
| Idoman Ltd. | President | 01/07/2008 |
Global Transplant Solutions, Inc.
 Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Global Transplant Solutions, Inc. provides solutions for the preservation of human organs. | Président | - |
Anciens postes connus de Albert Beraldo
| Sociétés | Poste | Fin |
|---|---|---|
| PURE GLOBAL CANNABIS INC. | Directeur/Membre du Conseil | 01/05/2020 |
| HELIX BIOPHARMA CORP. | Directeur/Membre du Conseil | 14/07/2017 |
Alveda Pharmaceuticals, Inc.
 Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alveda Pharmaceuticals, Inc. sells and distributes pharmaceuticals and medical devices. Its products are available in different sizes and formats including glass vials, ampoules, syringes, and polyampoules. The firm''s consulting services cover areas, such as, product development, warehousing and logistics, manufacturing, quality control testing and product analysis, and labeling and package development. It serves hospitals, buying groups, wholesalers, individual physicians, pharmacists, and patients. The company was founded in November 2006 and is headquartered in Toronto, Canada. | Fondateur | 01/11/2015 |
| TELESTA THERAPEUTICS INC | Directeur/Membre du Conseil | 01/02/2014 |
Bioniche Pharma Group Ltd.
 Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland. | President | 01/01/2006 |
Formation de Albert Beraldo
| University of Windsor | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| HELIX BIOPHARMA CORP. | Health Technology |
| MEDICENNA THERAPEUTICS CORP. | Health Technology |
| PURE GLOBAL CANNABIS INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Telesta Therapeutics, Inc.
 Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Telesta Therapeutics, Inc. is a biotechnology company, which focuses on the licensing/acquisition and development of transformational therapeutics for the treatment of serious human diseases, such as cancer, immune diseases, and targeted rare diseases. The company was founded by Graeme McRae in 1979 and is headquartered in Pointe-Claire, Canada. | Health Technology |
Bioniche Pharma Group Ltd.
Bioniche Pharma Group Ltd. Medical SpecialtiesHealth Technology Bioniche Pharma Group Ltd. is a specialty pharmaceutical company involved primarily in the development, manufacturing, and marketing of sterile injectable products. The company sells a number of non-branded products in the U.S. market for which it has received approved Abbreviated New Drug Applications. It also sells its branded product Suplasyn in 30 countries globally. The firm's products are sold to both the primary care and hospital markets in the U.S., Canada, and Europe. The company was founded in 2000 and is headquartered in Casla, Ireland. | Health Technology |
Alveda Pharmaceuticals, Inc.
Alveda Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Alveda Pharmaceuticals, Inc. sells and distributes pharmaceuticals and medical devices. Its products are available in different sizes and formats including glass vials, ampoules, syringes, and polyampoules. The firm''s consulting services cover areas, such as, product development, warehousing and logistics, manufacturing, quality control testing and product analysis, and labeling and package development. It serves hospitals, buying groups, wholesalers, individual physicians, pharmacists, and patients. The company was founded in November 2006 and is headquartered in Toronto, Canada. | Retail Trade |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Medicenna Therapeutics, Inc. develops and commercializes therapeutics for the treatment of central nervous system and urological cancers. It also develops proprietary therapeutic cytokines called Superkines, Superkines is powerful immune-system modulators that have significant therapeutic potential for the treatment of many forms of cancer and selected other diseases. Superkines can be fused to tumor cell-killing payloads to form Medicenna's proprietary Empowered Cytokines (EC's). The firm's EC's are being developed for the targeted treatment of cancer and are potentially vastly superior alternatives to other targeted cancer therapies such as Antibody Drug Conjugates. The company was founded by Fahar Merchan and Rosemina Merchant in 2011 and is headquartered in Vancouver, CA. | Health Technology |
| Idoman Ltd. | |
| Vetrepharm Canada, Inc. | |
Global Transplant Solutions, Inc.
Global Transplant Solutions, Inc. Medical/Nursing ServicesHealth Services Global Transplant Solutions, Inc. provides solutions for the preservation of human organs. | Health Services |